Lifetime smoking history and cause-specific mortality in a cohort study with 43 years of Follow-up

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Taghizadeh, Niloofar ^a,b   Vonk, Judith M ^a   Boezen, H Marike ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSTATE CANCER; RISK FACTOR; SMOKING; SMOKING HABIT; ADVERSE EFFECTS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FOLLOW UP; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE; TIME FACTOR; TOBACCO USE DISORDER; YOUNG ADULT;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SURVIVAL RATE; TIME FACTORS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84963811412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153310     Document Type: Article

References (39)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:.
2. Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, et al. Smoking and mortalitybeyond established causes. N Engl J Med. 2015; 372:631-640 doi:10.1056/NEJMsa1407211 PMID: 25671255.
3. Jurgens V, Ess S, Phuleria HC, Fruh M, Schwenkglenks M, Frick H, et al. Tobacco-related cancer mortality: projections for different geographical regions in Switzerland. Swiss Med Wkly 2013 25; 143: w13771doi:10.4414/smw.2013.13771 PMID: 23801107.
4. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007; 131:1557-1566. PMID: 17494805.
5. Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 2012; 12:385. doi:10.1186/1471-2407-12-385 PMID: 22943444.
6. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 38: Tobacco smoke and involuntary smoking. IARC 1986. p. 37-375.
7. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 83: Tobacco smoke and involuntary smoking. IARC 2004. p. 1017-1606.
8. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 100: personal habits and inddor combustion. IARC 2012.
9. Mendis S, Puska P, Norrving B editors. Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization), Geneva 2011.
10. Tashkin DP, Murray RP. Smoking cessation in chronic obstructive pulmonary disease. Respir Med 103: 963-974, 2009. doi:10.1016/j.rmed.2009.02.013 PMID: 19285850.
11. Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA. Burden of smoking on causespecific mortality: application to the Nurses' Health Study. Tob Control 2010; 19:248-254. doi10.1136/tc.2009.032839PMID: 20501499.
12. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96:99-106. PMID: 14734699.
13. Hurley MA. Light smoking at baseline predicts a higher mortality risk to women than to men; evidence from a cohort with long follow-up. BMC Public Health 2014; 14:95. doi:10.1186/1471-2458-14-95 PMID: 24479663.
14. Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010; 65:480-485. doi:10.1136/thx.2009.122002 PMID: 20522842.
15. McCormack VA, Agudo A, Dahm CC, Overvad K, Olsen A, Tjonneland A, et al. Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2010; 127:2402-2411. doi:10.1002/ijc.25252 PMID: 20162568.
16. Tverdal A, Bjartveit K. Health consequences of pipe versus cigarette smoking. Tob Control 2011; 20:123-130. doi:10.1136/tc.2010.036780 PMID: 20952559.
17. Streppel MT, Boshuizen HC, Ocke MC, Kok FJ, Kromhout D. Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: The Zutphen Study. Tob Control 2007; 16:107-113. PMID: 17400948.
18. Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology 2000; 11:261-268. PMID: 10784241.
19. Xu X, Rijcken B, Schouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350:1431-1434. PMID: 9371166.
20. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007; 26:2389-2430. PMID: 17031868.
21. World Health Organization. WHO global report on mortality attributable to tobacco. Geneva 2012: World Health Organization.
22. Agudo A, Bonet C, Travier N, Gonzalez CA, Vineis P, Bueno-de-Mesquita HB, et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol 2012; 30:4550-4557. doi:10.1200/JCO.2011.41.0183 PMID: 23169508.
23. Lee PN, Forey BA. Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review. BMC Cancer 2013; 13:189-2407-13-189.
24. Fry JS, Lee PN, Forey BA, Coombs KJ. Is the shape of the decline in risk following quitting smoking similar for squamous cell carcinoma and adenocarcinoma of the lung? A quantitative review using the2224-2260. doi:10.1016/S0140-6736(12)61766-8 PMID: 23245609negative exponential model. Regul Toxicol Pharmacol 2015; 72:49-57. doi: 10.1016/j.yrtph.2015.02.
25. Bosse Y, Postma DS, Sin DD, Lamontagne M, Couture C, Gaudreault N, et al. Molecular signature of smoking in human lung tissues. Cancer Res 2012; 72:3753-3763. PMID: 22659451.
26. Henschke CI, Yip R, Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006:180-184.
27. Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia 2013; 18:15-23. doi:10.1007/s10911-012-9269-x PMID: 23179580.
28. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, et al. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat 2012; 136:521-533. doi:10.1007/s10549-012-2276-1 PMID: 23053660.
29. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 2002; 11:953-971. PMID: 12376493.
30. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344:276-285. PMID: 11172156.
31. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162:502-514. PMID: 2178432.
32. Cotterchio M, Mirea L, Ozcelik H, Kreiger N. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada. Breast J. 2014; 20:468-480. doi:10.1111/tbj.12304PMID: 25052559.
33. Dossus L, Boutron-Ruault MC, Kaaks R, Gram IT, Vilier A, Fervers B, et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014; 134:1871-1888. doi:10.1002/ijc.28508 PMID: 24590452.
34. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. Br J Cancer 2002; 87:1234-45. PMID: 12439712.
35. Athyros VG, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin. 2013; 29:1263-1274. doi:10.1185/03007995.2013.827566 PMID: 23879722.
36. Lee PN, Fry JS, Thornton A. Estimating the decline in excess risk of cerebrovascular disease following quitting smoking-A systematic review based on the negative exponential model. Regul Toxicol Pharmacol 2014; 68:85-95. doi:10.1016/j.yrtph.2013.11.013 PMID: 24291341.
37. Shaper AG, Wannamethee SG, Walker M. Pipe and cigar smoking and major cardiovascular events, cancer incidence and all-cause mortality in middle-aged British men. Int J Epidemiol 2003; 32:802-808. PMID: 14559754.
38. Chang CM, Corey CG, Rostron BL, Apelberg BJ. Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health. 2015; 15:390. doi:10.1186/s12889-015-1617-5 PMID: 25907101.
39. Taghizadeh N, Vonk JM, Hospers JJ, Postma DS, de Vries EG, Schouten JP, et al. Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort. Cancer Causes Control. 2015; 26:99-109. doi:10.1007/s10552-014-0489-9 PMID: 25388801.